# Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)

> **NCT02268071** · NA · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 403 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Antihypertensive treatment will be stopped for 1 year unless hypertension recurrence

## Key facts

- **NCT ID:** NCT02268071
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-10
- **Primary completion:** 2020-10-21
- **Final completion:** 2020-10-21
- **Target enrollment:** 403 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02268071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02268071, "Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02268071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*